OBJECTIVES: The aim of this longitudinal study was to determine the long-term quality of life (QoL) of patients with chronic lymphocytic leukemia (CLL) and to investigate the relationship between QoL and sociodemographic and clinical parameters. METHODS: Ninety-seven patients suffering from CLL were asked to complete the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) four times over a period of 1 yr. Clinical data on disease and treatment characteristics were collected from medical records. For the purpose of comparison, EORTC QLQ-C30 scores were collected from 152 age- and gender-matched healthy controls. RESULTS: Seventy-six patients (age: median 68 yr, range 41-89) returned one or more questionnaires and were included in the statistical analysis. Compared with healthy controls CLL patients reported a lower QoL in almost all domains. No differences regarding QoL could be observed between CLL patients who had already received chemotherapy and those who had not. Moreover, female CLL patients were found to have remarkably lower QoL scores in the areas of emotional and social functioning than male patients. CONCLUSION: Patients suffering from CLL could have their QoL improved by more effective symptom management and psycho-oncological support. This could focus on specific symptoms such as fatigue and might have particular benefits for female patients with respect to their emotional and social well-being.
OBJECTIVES: The aim of this longitudinal study was to determine the long-term quality of life (QoL) of patients with chronic lymphocytic leukemia (CLL) and to investigate the relationship between QoL and sociodemographic and clinical parameters. METHODS: Ninety-seven patients suffering from CLL were asked to complete the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) four times over a period of 1 yr. Clinical data on disease and treatment characteristics were collected from medical records. For the purpose of comparison, EORTC QLQ-C30 scores were collected from 152 age- and gender-matched healthy controls. RESULTS: Seventy-six patients (age: median 68 yr, range 41-89) returned one or more questionnaires and were included in the statistical analysis. Compared with healthy controls CLLpatients reported a lower QoL in almost all domains. No differences regarding QoL could be observed between CLLpatients who had already received chemotherapy and those who had not. Moreover, female CLLpatients were found to have remarkably lower QoL scores in the areas of emotional and social functioning than male patients. CONCLUSION:Patients suffering from CLL could have their QoL improved by more effective symptom management and psycho-oncological support. This could focus on specific symptoms such as fatigue and might have particular benefits for female patients with respect to their emotional and social well-being.
Authors: T Takekiyo; K Dozono; S Nara; Y Murayama; N Minamihama; N Nakano; A Kubota; M Tokunaga; T Miyazono; S Takeuchi; Y Takatsuka; A Utsunomiya Journal: Bone Marrow Transplant Date: 2017-07-10 Impact factor: 5.483
Authors: Chris L Pashos; Christopher R Flowers; Neil E Kay; Mark Weiss; Nicole Lamanna; Charles Farber; Susan Lerner; Jeff Sharman; David Grinblatt; Ian W Flinn; Mark Kozloff; Arlene S Swern; Thomas K Street; Kristen A Sullivan; Gale Harding; Zeba M Khan Journal: Support Care Cancer Date: 2013-06-08 Impact factor: 3.603
Authors: Kathleen M Beusterien; John Davies; Michael Leach; David Meiklejohn; Jessica L Grinspan; Alison O'Toole; Steve Bramham-Jones Journal: Health Qual Life Outcomes Date: 2010-05-18 Impact factor: 3.186
Authors: Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps Journal: Blood Date: 2008-01-23 Impact factor: 22.113
Authors: Johannes Giesinger; Georg Kemmler; Verena Mueller; August Zabernigg; Beate Mayrbaeurl; Josef Thaler; Dietmar Ofner; Christian Pegger; Gerhard Rumpold; Barbara Weber; Barbara Sperner-Unterweger; Bernhard Holzner Journal: Qual Life Res Date: 2009-04-01 Impact factor: 4.147